Regeneron Pharmaceuticals
REGN
#118
Rank
€113.28 B
Marketcap
1.028 €
Share price
-0.69%
Change (1 day)
33.16%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): 34,71 €

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 33,71 €. In 2022 the company made an earnings per share (EPS) of 36,57 € a decrease over its 2021 EPS that were of 68,99 €.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)34,71 €-5.07%
202236,57 €-47%
202168,99 €133.36%
202029,56 €69.13%
201917,48 €-14.44%
201820,43 €100.71%
201710,18 €31.78%
20167,72 €38.96%
20155,56 €72.55%
20143,22 €-17.55%
20133,91 €-44.98%
20127,10 €-422.54%
2011-2,20 €92.13%
2010-1,15 €49.41%
2009-0,77 €-15.84%
2008-0,91 €-36.88%
2007-1,44 €-9.6%
2006-1,60 €4.12%
2005-1,53 €-323.68%
20040,69 €-135.51%
2003-1,93 €-24.38%
2002-2,55 €56.35%
2001-1,63 €187.3%
2000-0,57 €-10.05%
1999-0,63 €177.78%
1998-0,23 €-35.71%
1997-0,35 €-68.42%
1996-1,12 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
12,77 €-62.13%🇺🇸 USA
-3,71 €-111.00%🇺🇸 USA
16,66 €-50.59%🇺🇸 USA
12,71 €-62.30%🇺🇸 USA
3,37 €-89.99%🇨🇭 Switzerland
2,87 €-91.49%🇫🇷 France